Download presentation
Presentation is loading. Please wait.
Published bySteffen Ravn Modified over 6 years ago
1
Community Practice Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Syndrome Daniel G. Luba, James A. DiSario, Colleen Rock, Devki Saraiya, Kelsey Moyes, Krystal Brown, Kristen Rushton, Maydeen M. Ogara, Mona Raphael, Dayna Zimmerman, Kimmie Garrido, Evelyn Silguero, Jonathan Nelson, Matthew B. Yurgelun, Fay Kastrinos, Richard J. Wenstrup, Sapna Syngal Clinical Gastroenterology and Hepatology Volume 16, Issue 1, Pages (January 2018) DOI: /j.cgh Copyright © 2018 AGA Institute Terms and Conditions
2
Figure 1 Personal/family history data collected by the patient self-administered PREMM1,2,6. Clinical Gastroenterology and Hepatology , 49-58DOI: ( /j.cgh ) Copyright © 2018 AGA Institute Terms and Conditions
3
Figure 2 Sample output of the patient self-administered PREMM1,2,6. NCCN, National Comprehensive Cancer Network. Clinical Gastroenterology and Hepatology , 49-58DOI: ( /j.cgh ) Copyright © 2018 AGA Institute Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.